Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis. Reardon J, Perumal JS Drug Des Devel Ther. 2013; 7:1187-1193. Epub 2013 Oct 09. PMID: 24143075. Abstract CommentRecommendBookmarkWatch